How can we improve platelet preparation and storage?
暂无分享,去创建一个
[1] J. Bring,et al. Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets: Comparison between Platelet Concentrates Derived from Pooled Buffy Coates and Apheresis , 1996, Vox sanguinis.
[2] F. Claas,et al. Occurrence of Allogeneic HLA and Non-HLA Antibodies After Transfusion of Prestorage Filtered Platelets and Red Blood Cells: A Prospective Study , 1995 .
[3] R. Stromberg,et al. In vitro and in vivo effects of prestorage filtration of apheresis platelets , 1995, Transfusion.
[4] A. Giulivi,et al. Effect of filtration of platelet concentrates on the accumulation of cytokines and platelet release factors during storage , 1995, Transfusion.
[5] D. Rhenen,et al. Evaluation of a new citrate‐acetate‐NaCl platelet additive solution for the storage of white cell‐reduced platelet concentrates obtained from half‐strength CPD pooled buffy coats , 1995, Transfusion.
[6] Edward J. Lee,et al. White cell reduction in platelet concentrates and packed red cells by filtration: a multicenter clinical trial. The Trap Study Group , 1995, Transfusion.
[7] A. J. Bell. Peripheral blood stem cell transplants in lymphoma. , 1994, Transfusion science.
[8] V. Kretschmer,et al. A contribution to the indications for platelet transfusion and determination of its therapeutic efficacy. , 1994, Transfusion science.
[9] Yun-Fai Chris Lau,et al. A prospective study of symptomatic bacteremia following platelet transfusion and of its management , 1994, Transfusion.
[10] M. Blajchman,et al. BACTERIAL CONTAMINATION OF CELLULAR BLOOD COMPONENTS , 1994, Vox sanguinis.
[11] S. Holme. Platelet storage in a liquid environment. , 1994, Transfusion science.
[12] L. Corash,et al. Photochemical inactivation of pathogenic bacteria in human platelet concentrates. , 1994, Blood.
[13] M. Lundholm,et al. Novel automated microbial screening of platelet concentrates , 1994, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[14] S. Murphy,et al. Roles of acetate and phosphate in the successful storage of platelet concentrates prepared with an acetate‐containing additive solution , 1993, Transfusion.
[15] H. Gulliksson. Storage of platelets in additive solutions: the effect of citrate and acetate in in vitro studies , 1993, Transfusion.
[16] S Murphy,et al. Platelet quality after 15‐day storage of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium , 1992, Transfusion.
[17] W. Heaton,et al. Extended Storage of Platelets in an Artificial Medium with the Platelet Activation Inhibitors Prostaglandin E1 and Theophylline 1 , 1991, Vox sanguinis.
[18] D. Roos,et al. In vitro Evaluation of Buffy‐Coat‐Derived Platelet Concentrates Stored in a Synthetic Medium 1 , 1991, Vox sanguinis.
[19] P. Withers,et al. Alternative Fuels for Platelet Storage: A Metabolic Study , 1990, Vox sanguinis.
[20] P. Whitley,et al. Platelet Storage Lesions in Second‐Generation Containers: Correlation with in vivo Behavior with Storage up to 14 Days , 1990, Vox sanguinis.
[21] T. Gunter,et al. Mechanisms by which mitochondria transport calcium. , 1990, The American journal of physiology.
[22] Riitta Kekomäki,et al. Effective prophylaxis against platelet refractoriness in multitransfused patients by use of leukocyte-free blood components , 1990 .
[23] D. Riccardi,et al. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose‐free crystalloid medium , 1989, Transfusion.
[24] J. Hansen,et al. Centrifugation of Very Freshly Donated Blood May Yield Platelets Unstable to Storage in the New Generation of Containers , 1989, Vox sanguinis.
[25] S. Murphy,et al. Plasma free fatty acid metabolism during storage of platelet concentrates for transfusion , 1987, Transfusion.
[26] G. Rock,et al. Platelet storage in a plasma‐free medium , 1985, Transfusion.
[27] J. Fratantoni,et al. Aberrant morphology of platelets stored in five day containers. , 1984, Thrombosis research.
[28] R. Kahn,et al. Improved storage of platelets for transfusion in a new container. , 1982, Blood.
[29] R. Aster,et al. Relative hemostatic effectiveness of human platelets stored at 4 degrees and 22 degrees C. , 1978, The Journal of laboratory and clinical medicine.
[30] J. Bring,et al. Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets , 1996 .
[31] C. Högman,et al. Buffy-Coat-Derived Platelet Concentrates Prepared from Half-Strength Citrate CPD and CPD Whole-Blood Units , 1995 .
[32] K. Pflüger,et al. Determination of bleeding risk in thrombocytopenic patients receiving platelet substitution , 1993 .
[33] S. Holme. Effect of additive solutions on platelet biochemistry. , 1992, Blood cells.
[34] Bode Ap. Platelet activation may explain the storage lesion in platelet concentrates. , 1990 .
[35] C. Prowse. Donation Procedure: Collection Lesion, Fibrinopeptide A, and Factor VIII , 1985 .
[36] C. S. Sibinga,et al. Plasma Fractionation and Blood Transfusion , 1985, Developments in Hematology and Immunology.